Wednesday, September 2, 2015

Janssen, Bayer HealthCare announce results from landmark studies evaluating safety profile of XARELTO in NVAF patients

Janssen Pharmaceuticals, Inc., and its development partner, Bayer HealthCare, today announced…
from Total Knee Replacement Recovery http://totalkneereplacementrecovery.tumblr.com/post/128104857079

from Tumblr http://wendyjborst.tumblr.com/post/128104962655


No comments:

Post a Comment